SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001047469-15-007618
Filing Date
2015-09-30
Accepted
2015-09-30 10:56:14
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-1/A a2226145zf-1a.htm F-1/A 3347076
2 EX-5.1 a2226145zex-5_1.htm EX-5.1 64218
3 EX-23.1 a2226145zex-23_1.htm EX-23.1 4115
4 EX-23.2 a2226145zex-23_2.htm EX-23.2 4257
5 EX-23.3 a2226145zex-23_3.htm EX-23.3 3409
6 G400376.JPG g400376.jpg GRAPHIC 20191
7 G456181.JPG g456181.jpg GRAPHIC 121631
8 G815679.JPG g815679.jpg GRAPHIC 42419
9 G715597.JPG g715597.jpg GRAPHIC 34175
10 G454757.JPG g454757.jpg GRAPHIC 17289
11 G852078.JPG g852078.jpg GRAPHIC 30729
  Complete submission text file 0001047469-15-007618.txt   3791932
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: F-1/A | Act: 33 | File No.: 333-206654 | Film No.: 151133001
SIC: 2834 Pharmaceutical Preparations